Giverny Capital Inc. Buys New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Giverny Capital Inc. acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 405 shares of the medical equipment provider’s stock, valued at approximately $211,000.

A number of other large investors have also recently modified their holdings of ISRG. Vanguard Group Inc. raised its holdings in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock worth $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after acquiring an additional 243,802 shares in the last quarter. Fisher Asset Management LLC increased its stake in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after acquiring an additional 86,488 shares in the last quarter. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth about $2,401,493,000. Finally, Invesco Ltd. boosted its stake in Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock worth $2,165,184,000 after acquiring an additional 295,025 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ISRG shares. Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Evercore ISI increased their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays raised their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Price Performance

ISRG stock opened at $493.60 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $175.81 billion, a P/E ratio of 77.00, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The stock’s fifty day moving average price is $532.72 and its 200-day moving average price is $532.36.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company’s stock, valued at $271,397.94. This trade represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.